Pierre Lozeron

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

Journal: Scientific reports

Published: February 25, 2026

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

Journal: European journal of neurology

Published: January 29, 2026

Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.

Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy.

Journal: European journal of neurology

Published: April 08, 2025

Evolution of Nerve Conduction Demyelinating Parameters Between Baseline and Treatment Cessation May Not Be Predictive of Relapse in IVIg-Responsive CIDP Patients.

Evolution of Nerve Conduction Demyelinating Parameters Between Baseline and Treatment Cessation May Not Be Predictive of Relapse in IVIg-Responsive CIDP Patients.

Journal: Muscle & nerve

Published: February 25, 2025

Primary Neurolymphomatosis: A Literature Review.

Primary Neurolymphomatosis: A Literature Review.

Journal: European journal of neurology

Published: December 03, 2024

Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Journal: Journal of neuroimmunology

Published: February 28, 2024

Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases.

Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases.

Journal: British journal of haematology

Published: December 29, 2023

Reply to letter on What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse.

Reply to letter on What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse.

Journal: European journal of neurology

Published: December 06, 2023

EEG and acute confusional state at the emergency department.

EEG and acute confusional state at the emergency department.

Journal: Neurophysiologie clinique = Clinical neurophysiology

Published: April 20, 2023

How to distinguish Guillain-Barré syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study.

How to distinguish Guillain-Barré syndrome from nitrous oxide-induced neuropathy: A 2-year, multicentric, retrospective study.

Journal: European journal of neurology

Published: March 27, 2023

Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients.

Parasympathetic autonomic dysfunction is more often evidenced than sympathetic autonomic dysfunction in fluctuating and polymorphic symptoms of "long-COVID" patients.

Journal: Scientific reports

Published: January 17, 2023

Predicting neurological outcome after cardiac arrest by combining computational parameters extracted from standard and deviant responses from auditory evoked potentials.

Predicting neurological outcome after cardiac arrest by combining computational parameters extracted from standard and deviant responses from auditory evoked potentials.

Journal: Frontiers in neuroscience

Published: July 07, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026